Fox Lynne P. 4
4 · Amalgamated Financial Corp. · Filed Nov 3, 2025
Insider Transaction Report
Form 4
Fox Lynne P.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-10-30$12.00/sh+4,820$57,840→ 26,734 total - Exercise/Conversion
Common Stock
2025-10-30$13.75/sh+7,020$96,525→ 31,373 total - Exercise/Conversion
Common Stock
2025-10-30$14.65/sh+6,560$96,104→ 34,465 total - Sale
Common Stock
2025-10-31$27.34/sh−8,949$244,624→ 22,276 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-30−6,560→ 0 totalExercise: $14.65From: 2018-01-01Exp: 2028-01-01→ Common Stock (6,560 underlying) - Tax Payment
Common Stock
2025-10-30$27.56/sh−3,468$95,569→ 27,905 total - Award
Common Stock
2025-11-01+2,568→ 24,844 total - Tax Payment
Common Stock
2025-10-30$27.56/sh−2,381$65,614→ 24,353 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-30−7,020→ 0 totalExercise: $13.75From: 2017-01-01Exp: 2027-01-01→ Common Stock (7,020 underlying) - Sale
Common Stock
2025-08-07$27.49/sh−300$8,247→ 21,914 total - Tax Payment
Common Stock
2025-10-30$27.56/sh−3,240$89,286→ 31,225 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-30−4,820→ 0 totalExercise: $12.00From: 2016-01-01Exp: 2026-01-01→ Common Stock (4,820 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 - $27.63 . The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]The reported transaction involved the reporting person's receipt of a grant of 2,568 restricted stock units. The restricted stock units vest immediately upon grant, in consideration of the Company's termination of the stock option program and the Director's early exercise of all outstanding and vested stock options on October 30, 2025.